Featured News Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality? Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants. Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine Image news | Apr 15 2024 Wu Tsai Neurosciences Institute Neuroscience sheds light on childhood gut disorders The recent discovery that intestinal neurons normally self-organize into a striped pattern around the time of birth could help explain wide-ranging GI disorders in children, say Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and her team News Filter & Sort Sort by ThemeNeuroHealth NeuroDiscovery NeuroEngineering News Type (-) Knight Initiative news Featured News Research news Institute News Press coverage Researcher profiles Podcast episodes Director's messages Awards and honors Sort by Newest to oldest Oldest to newest Image news | Apr 18 2024 Stanford Report Seven Stanford faculty named AAAS Fellows Seven Stanford faculty, including Knight Initiative Director Tony Wyss-Coray, are among the 502 new fellows of the American Association for the Advancement of Science. Image news | Apr 9 2024 Scope Blog Why detecting the earliest biological signs of Parkinson’s disease is so crucial Q&A with Wu Tsai Neuro affiliate Kathleen Poston about her work past and present on Parkinson’s disease. Poston studies the pathophysiology underlying the cognitive, behavioral and motor symptoms characteristic of Parkinson’s. Image news | Apr 9 2024 Stanford Report Phil Knight honored with Uncommon Citizen award A dedicated philanthropist and Stanford GSB alum, Knight has provided game-changing support for schools and initiatives across campus. Image news | Mar 27 2024 Knight Initiative for Brain Resilience Research links age-related inflammation, microglia and Alzheimer’s Disease Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research. Image news | Mar 20 2024 Knight Initiative for Brain Resilience Alzheimer’s risk gene tied to fatty blobs in brain’s immune cells Recent research supported by the Knight Initiative has identified a link between lipid droplets in the microglia to a known genetic risk factor for AD. Image news | Mar 19 2024 Knight Initiative for Brain Resilience Alzheimer’s and Parkinson’s biomarkers show promise for early diagnosis Two new studies supported by the Knight Initiative highlight groundbreaking new early biomarkers for the diagnosis and treatment of neurodegenerative disease. Image news | Mar 18 2024 Stanford Medicine Weight loss caused by common diabetes drug tied to “anti-hunger” molecule in stu... Research supported by the Knight Initiative found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates the production of lac-phe, a molecule abundant after exercise. Image news | Mar 13 2024 Stanford Medicine One step back: Why the new Alzheimer’s plaque-attack drugs don’t work A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Wu Tsai Neuro and Knight Initiative affiliate Mike Greicius explains why. Pagination Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Next page
Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality?
Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.
Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine
Image news | Apr 15 2024 Wu Tsai Neurosciences Institute Neuroscience sheds light on childhood gut disorders The recent discovery that intestinal neurons normally self-organize into a striped pattern around the time of birth could help explain wide-ranging GI disorders in children, say Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and her team
Image news | Apr 18 2024 Stanford Report Seven Stanford faculty named AAAS Fellows Seven Stanford faculty, including Knight Initiative Director Tony Wyss-Coray, are among the 502 new fellows of the American Association for the Advancement of Science.
Image news | Apr 9 2024 Scope Blog Why detecting the earliest biological signs of Parkinson’s disease is so crucial Q&A with Wu Tsai Neuro affiliate Kathleen Poston about her work past and present on Parkinson’s disease. Poston studies the pathophysiology underlying the cognitive, behavioral and motor symptoms characteristic of Parkinson’s.
Image news | Apr 9 2024 Stanford Report Phil Knight honored with Uncommon Citizen award A dedicated philanthropist and Stanford GSB alum, Knight has provided game-changing support for schools and initiatives across campus.
Image news | Mar 27 2024 Knight Initiative for Brain Resilience Research links age-related inflammation, microglia and Alzheimer’s Disease Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research.
Image news | Mar 20 2024 Knight Initiative for Brain Resilience Alzheimer’s risk gene tied to fatty blobs in brain’s immune cells Recent research supported by the Knight Initiative has identified a link between lipid droplets in the microglia to a known genetic risk factor for AD.
Image news | Mar 19 2024 Knight Initiative for Brain Resilience Alzheimer’s and Parkinson’s biomarkers show promise for early diagnosis Two new studies supported by the Knight Initiative highlight groundbreaking new early biomarkers for the diagnosis and treatment of neurodegenerative disease.
Image news | Mar 18 2024 Stanford Medicine Weight loss caused by common diabetes drug tied to “anti-hunger” molecule in stu... Research supported by the Knight Initiative found that metformin, a commonly prescribed diabetes drug associated with moderate weight loss, stimulates the production of lac-phe, a molecule abundant after exercise.
Image news | Mar 13 2024 Stanford Medicine One step back: Why the new Alzheimer’s plaque-attack drugs don’t work A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Wu Tsai Neuro and Knight Initiative affiliate Mike Greicius explains why.